NCT02761434

Brief Summary

Data from experimental animals and human epidemiological studies have suggested that hypohydration and/or low water intake is linked to poor glucose regulation and diabetes. The aim of this study is to investigate the effects of cellular dehydration on glucose in healthy non-diabetic individuals. METHODS: 60 males and females (30-55 y) will will undergo two experimental trials (ISO and HYP), consisting of a 2-h intravenous infusion of isotonic or hypertonic saline on two separate occasions, followed by a 4-h oral glucose tolerance test. Blood samples were taken from an antecubital vein in 30-min intervals starting at baseline for assessment of fluid and glucose regulating factors. Thirst will be assessed via visual analog following each blood sample. Energy substrate oxidation will be calculated via indirect calorimetry every 60 min.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 13, 2016

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

April 26, 2016

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 4, 2016

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2017

Completed
Last Updated

May 31, 2017

Status Verified

May 1, 2017

Enrollment Period

1.1 years

First QC Date

April 26, 2016

Last Update Submit

May 27, 2017

Conditions

Keywords

copeptinvasopressindehydrationinsulin resistanceDiabetesGlucose regulation

Outcome Measures

Primary Outcomes (3)

  • Glucose area under the curve during the 4 h following ingestion of 75 g glucose

    the area under the glucose curve (AUC) in mg/dL x min

    Within 4 hours of the hypertonic saline infusion

  • Insulin area under the curve during the 4 h post ingestion following ingestion of 75 g glucose

    the area under the insulin curve (AUC) in microU/mL x min

    Within 4 hours of the hypertonic saline infusion

  • Insulin sensitivity by matsuda & quicki Index

    Within 4 hours of the hypertonic saline infusion

Secondary Outcomes (3)

  • Thirst, mouth dryness

    during the experiment every 30 min for the 6 ½ hours of the experiment

  • Resting metabolic rate

    every 60 min of the experiment for the 6 ½ hours of the experiment

  • Energy substrate oxidation

    every 60 min of the experiment for the 6 ½ hours of the experiment

Study Arms (2)

Dehydration

ACTIVE COMPARATOR

Infusion of 3% sodium chloride for osmotic stimulation of vasopressin

Other: Hypertonic Saline (3% NaCl)

Euhydration

PLACEBO COMPARATOR

Infusion of 0.9% sodium chloride that will induce similar expansion of plasma volume without any significant change in osmolality and vasopressin

Other: Isotonic Saline (0.9% NaCl)

Interventions

0.1 ml of 3% NaCl per kg of body weight per minute

Dehydration

0.1 ml of 0.9% NaCl per kg of body weight per minute

Euhydration

Eligibility Criteria

Age30 Years - 50 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Males or females of age 30-50 y old
  • Signed Informed Consent prior to the initiation of any trial procedure
  • Sedentary lifestyle

You may not qualify if:

  • Body Mass Index (BMI) greater than 35 kg/m2, below 18.5 kg/m2, and between 25 and 28 kg/m2
  • Surgical operation on digestive tract, except possible appendectomy
  • Regular smoker within the past 6 months
  • Diagnosed diabetes (Type I or Type II)
  • Previous diagnosis of cardiovascular disease including hypertension
  • Inability to participate in the entire study
  • Drastic change in weight in the last month (more than 3 kg)
  • Serotonin re-uptake inhibitors (i.e. Prozac)
  • Impaired kidney or liver function
  • Insulin therapy
  • injectable contraceptives
  • Currently taking medications that impair water balance
  • Commuting by bike the day of the experiment
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Arkansas

Fayetteville, Arkansas, 72701, United States

Location

Related Publications (1)

  • Jansen LT, Suh H, Adams JD, Sprong CA, Seal AD, Scott DM, Butts CL, Melander O, Kirkland TW, Vanhaecke T, Dolci A, Lemetais G, Perrier ET, Kavouras SA. Osmotic stimulation of vasopressin acutely impairs glucose regulation: a counterbalanced, crossover trial. Am J Clin Nutr. 2019 Dec 1;110(6):1344-1352. doi: 10.1093/ajcn/nqz236.

MeSH Terms

Conditions

Insulin ResistanceDiabetes InsipidusDehydrationDiabetes Mellitus

Interventions

Saline Solution, HypertonicSodium Chloride

Condition Hierarchy (Ancestors)

HyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesPituitary DiseasesEndocrine System DiseasesWater-Electrolyte ImbalancePathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Hypertonic SolutionsSolutionsPharmaceutical PreparationsChloridesHydrochloric AcidChlorine CompoundsInorganic ChemicalsSodium Compounds

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

April 26, 2016

First Posted

May 4, 2016

Study Start

April 13, 2016

Primary Completion

May 15, 2017

Study Completion

May 15, 2017

Last Updated

May 31, 2017

Record last verified: 2017-05

Locations